Details for 2023215626

Up to date per 09.04.2026

Actions

Title / Product Name

MIRIKIZUMAB ZUR BEHANDLUNG VON COLITIS ULCEROSA

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2023215626

EP Publication Number

4327866

E-Number

1865516

Language

PCT Number

Publication Date

28.02.2024 A

10.12.2025 B1

Registration Date

10.12.2025

AT Publication Date

15.12.2025

Application Date

28.03.2019

Registration Number

Priorities

30.03.2018

201862650314 P

IPC

A61K 39/395 20060101AFI20240215BHEP

Maximum Duration of Protection

28.03.2039

Owner

Eli Lilly and CompanyLilly Corporate Center Indianapolis, IN 46285US

Representative

No representatives present

Inventor

CANAVAN, James Benedict Indianapolis, 46206-6288US

FRIEDRICH, Stuart William Indianapolis, 46206-6288US

KRUEGER, Kathryn Ann Indianapolis, 46206-6288US

MILCH, Catherine Indianapolis, 46206-6288US

TUTTLE, Jay Lawrence Indianapolis, 46206-6288US

Information about Fees